Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets

NCT01083290 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Orion Corporation, Orion Pharma